MedicaidCoverageLow impact
Newsletter Vol. 13, No. 11
New Jersey Medicaid·NJ · Pharmacy·Pharmacy
Effective date
Feb 10, 2003
We identified it
Jun 20, 2026
Summary
Two new pharmaceutical manufacturers (Xactdose, Inc. and Fleming & Company) have been added to the New Jersey PAAD (Pharmaceutical Assistance to the Aged and Disabled) Drug Rebate Program with effective dates of 02/10/03 and 02/28/03 respectively. Providers must recognize these labeler codes (50962 and 00256) when processing PAAD prescriptions to ensure proper drug coverage and rebate eligibility.
Action Required
By February 28, 2003: Pharmacy staff and providers processing PAAD prescriptions must update their pharmacy management systems and reference materials to recognize labeler codes 50962 (Xactdose, Inc.) and 00256 (Fleming & Company) as approved PAAD manufacturers. Ensure that prescriptions from these manufacturers are processed under the PAAD program rather than being rejected or directed to alternative coverage. No other action is required; this is informational guidance to prevent claim processing delays or denials for eligible PAAD beneficiaries receiving drugs from these newly approved manufacturers.